Caption Management, LLC Adaptimmune Therapeutics PLC Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$7.66 - $10.78 $199,160 - $280,280	-26,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.58 - $12.1 $67,080 - $314,600	26,000 New	26,000 $260,000
Q1 2019 May 14, 2019	SELL	$3.63 - $6.06 $184,984 - $308,817	-50,960 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$3.76 - $14.16 $93,849 - $353,433	24,960 Added 96.0%	50,960 $293,000
Q3 2018 Nov 14, 2018	BUY	$8.27 - $13.56 $215,020 - $352,560	26,000 New	26,000 $353,000

152M

78.5K

36.5K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $121M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.